Prevalence of primary immune thrombocytopenia in Oklahoma

被引:69
|
作者
Terrell, Deirdra R. [1 ]
Beebe, Laura A. [1 ]
Neas, Barbara R. [1 ]
Vesely, Sara K. [1 ]
Segal, Jodi B. [2 ]
George, James N. [1 ,3 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73126 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Med, Oklahoma City, OK 73126 USA
关键词
QUALITY-OF-LIFE; PURPURA; ADULTS; CHILDHOOD; CHILDREN; PATIENT;
D O I
10.1002/ajh.23262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 20032004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.79.5) per 100,000 children, 12.1 (95% CI: 11.113.0) per 100,000 adults, and 11.2 (95% CI: 10.412.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:848 / 852
页数:5
相关论文
共 50 条
  • [1] Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists
    Lu, Kaelyn H.
    George, James N.
    Vesely, Sara K.
    Terrell, Deirdra R.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (03): : 190 - 194
  • [2] Primary immune thrombocytopenia: Experience of a specialised clinic
    Rodriguez-Vigil Iturrate, Carmen
    Sanz de Miguel, Maria Pilar
    Martinez Faci, Cristina
    Murillo Sanjuan, Laura
    Calvo Escribano, Carlota
    Garcia Iniguez, Juan Pablo
    Samper Villagrasa, Maria Pilar
    ANALES DE PEDIATRIA, 2020, 93 (01): : 16 - 23
  • [3] Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries
    Liang, Yi
    Rascati, Karen
    Richards, Kristin
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1315 - 1322
  • [4] Fatigue in adult patients with primary immune thrombocytopenia
    Newton, Julia L.
    Reese, Jessica A.
    Watson, Shirley I.
    Vesely, Sara K.
    Bolton-Maggs, Paula H. B.
    George, James N.
    Terrell, Deirdra R.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (05) : 420 - 429
  • [5] Markers of refractory primary immune thrombocytopenia
    Moulis, Guillaume
    Garabet, Lamya
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (01) : 112 - 118
  • [6] Primary immune thrombocytopenia: a 'diagnosis of exclusion'?
    Visweshwar, Nathan
    Ayala, Irmel
    Jaglal, Michael
    Killeen, Robert
    Sokol, Lubomir
    Laber, Damian A.
    Manoharan, Arumugam
    BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (06) : 289 - 294
  • [7] Romiplostim for the treatment of primary immune thrombocytopenia
    Janssens, Ann
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (02) : 133 - 144
  • [8] Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
    Terrell, Deirdra R.
    Neunert, Cindy E.
    Cooper, Nichola
    Heitink-Polle, Katja M.
    Kruse, Caroline
    Imbach, Paul
    Kuehne, Thomas
    Ghanima, Waleed
    MEDICINA-LITHUANIA, 2020, 56 (12): : 1 - 10
  • [9] Prevalence of anti-glycoprotein V in patients with primary immune thrombocytopenia
    Azzazi, Mohamed O.
    Nabeeh, Nermeen A.
    Mohamed, Asmaa M.
    Abdelfatah, Rana G.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (01): : 29 - 35
  • [10] Treatment of Pediatric Primary Immune Thrombocytopenia With Thrombopoietin Receptor Agonists
    Kuehne, Thomas
    SEMINARS IN HEMATOLOGY, 2015, 52 (01) : 25 - 30